26.12.2014 Views

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

Clinical Biochemistry of Domestic Animals (Sixth Edition) - UMK ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

292<br />

Chapter | 10 Hemostasis<br />

The proteins stored in the α -granules are either synthesized<br />

by megakaryocytes or are endocytosed by platelets<br />

as they circulate around the body ( Reed, 2004 ). Like<br />

other endocytotic cell types, platelets contain lysosomes<br />

that release hydrolases. It has been suggested that these<br />

hydrolases assist in the elimination <strong>of</strong> circulating platelet<br />

aggregates to prevent inappropriate thrombus formation<br />

( Rendu and Brohard-Bohn, 2001 ). Mitochondria and<br />

cytoplasmic glycogen stores provide the energy to support<br />

the granule exocytotic secretory process in activated<br />

platelets ( Flaumenhaft, 2003 ). This exocytosis process<br />

involves contraction <strong>of</strong> the actin-myosin cytoskeleton and<br />

the apposition and fusion <strong>of</strong> each granule membrane with<br />

the platelet plasma membrane ( Escolar and White, 1991 ;<br />

Reed, 2004 ; Rendu and Brohard-Bohn, 2001 ). In addition<br />

to the extrusion <strong>of</strong> granule contents, the alteration in<br />

platelet morphology results in the exposure <strong>of</strong> both GPIIb-<br />

IIIa integrin complexes and membrane markers, such as<br />

CD62 and CD63, on the surface <strong>of</strong> the activated platelets<br />

( Polasek, 2004 ). CD62, also referred to as P-selectin, has<br />

been used as a marker <strong>of</strong> activated canine platelets ( Moritz<br />

et al ., 2003a, 2003b ).<br />

3. Platelet Activation<br />

a. Immobilized Agonists<br />

When the ECM is damaged, various macromolecules interact<br />

with platelets as they roll along the exposed subendothelial<br />

surface collagen. Of these, collagen-bound vWF is<br />

considered to be the most important for the initial tethering<br />

and adhesion <strong>of</strong> platelets to areas <strong>of</strong> vascular damage<br />

( Nieswandt and Watson, 2003 ). This occurs through the<br />

interaction <strong>of</strong> collagen-bound vWF with the GPIb-IX-V<br />

integrin complex. However, at the medium and high shear<br />

rates found in arteries and arterioles, this reaction is reversible<br />

and must be followed by the more stable binding <strong>of</strong><br />

collagen to its specific platelet receptors α 2 β 1 and GPVI<br />

( Table 10-2 ). The initial interaction between platelets and<br />

the ECM through vWF-GPIb-IX-V binding is important<br />

because it induces activation <strong>of</strong> intracellular tyrosine<br />

kinases, causing increased affinity <strong>of</strong> α 2 β 1 for collagen<br />

binding as well as an increase in the affinity <strong>of</strong> GPIIb-IIIa<br />

for a variety <strong>of</strong> ligands including fibrinogen, vWF, fibronectin,<br />

vitronectin, and thrombospondin ( Calvete, 2004 ).<br />

The two collagen receptors, α 2 β 1 and GPVI, are thought<br />

to have complementary functions in platelet adhesion<br />

( Andrews and Berndt, 2004 ). In human platelets, α 2 β 1<br />

binds collagen in an Mg 2 -dependent manner, tethering<br />

platelets to the ECM before platelet activation. At the<br />

same time, collagen- α 2 β 1 binding facilitates the interaction<br />

between collagen and GPVI in a nontyrosine kinasedependent<br />

reaction. GPVI is currently considered to be the<br />

major collagen receptor because it initiates shape change,<br />

activation, and secretion reactions following platelet adhesion<br />

( Nieswandt and Watson, 2003 ). In mouse platelets,<br />

it appears that GPVI provides the primary collagen signal<br />

that activates and recruits α 2 β 1 integrins to the surface <strong>of</strong><br />

the platelet so that collagen signaling is amplified ( Chen<br />

and Kahn, 2003 ). One <strong>of</strong> the important intracellular pathways<br />

activated as a result <strong>of</strong> collagen binding to GPVI is<br />

the PLC pathway, specifically the activation <strong>of</strong> the PLC γ 2<br />

isomer ( Savage et al ., 2001 ).<br />

As platelets adhere to collagen and receptor activation<br />

occurs, they lose their resting discoid shape and extend<br />

pseudopods as they spread over the endothelial surface<br />

( Escolar and White, 1991 ; Gentry, 2000b ). This increases<br />

the surface area <strong>of</strong> the platelets, which, coupled with the<br />

clustering <strong>of</strong> integrin molecules on platelet membranes and<br />

the increase in integrin affinity, results in the formation<br />

<strong>of</strong> irreversible platelet-endothelial binding via vWF and<br />

the GPIb-IX-V receptors and platelet-platelet interactions<br />

via vWF and fibrinogen binding to GPIIb-IIIa receptors<br />

( Boudreaux, 1996 ; Savage et al ., 2001 ). The GPIb-IX-V<br />

receptor is a sialoglycoprotein-rich complex that contributes<br />

to the net negative charge on the platelet surface. GPIb<br />

consists <strong>of</strong> two disulfide-linked subunits, GPIb α and GPIb β ,<br />

that are associated with GPIX in a 1:1 complex ( Lopez and<br />

Dong, 1997 ). In mouse platelets, the activation function<br />

<strong>of</strong> vWF binding to GPIb-IX-V is, like collagen binding to<br />

the GPVI receptor, dependent on tyrosine phosphorylation<br />

( Shattil and Newman, 2004 ). This phosphorylation activity<br />

is dependent on the FcR, a molecule that associates noncovalently<br />

with GPVI and GPIb-IX-V. FcR γ is a component<br />

<strong>of</strong> the multisubunit high-affinity receptor for immunoglobulin<br />

(IgE), and its tyrosine-phosphorylated active motif<br />

helps to recruit tyrosine kinases to the glycoprotein receptors.<br />

The binding site for vWF on the receptor complex is<br />

localized to a site on the GPIb β chain, which can also serve<br />

as a thrombin receptor. The outside-in signaling events<br />

that ensue from vWF-GPIb β binding include activation<br />

<strong>of</strong> protein kinase C (PKC), protein kinase G (PKG) and<br />

phosphoinositol 3 kinase (PI3K), elevation <strong>of</strong> intracellular<br />

Ca 2 , and rearrangement <strong>of</strong> the cytoskeleton ( Gibbins,<br />

2004 ). These reactions complete the irreversible adhesion<br />

<strong>of</strong> the activated platelet monolayer to the damaged endothelium.<br />

As part <strong>of</strong> the defense mechanism against inappropriate<br />

platelet adhesion and aggregation, GPIb-IX-V<br />

receptors only bind vWF immobilized on collagen and not<br />

soluble vWF, except under conditions <strong>of</strong> high shear flow<br />

rates ( Lopez and Dong, 1997 ).<br />

The continued growth <strong>of</strong> the platelet plug requires<br />

platelet-platelet adhesion that is accomplished through a<br />

process described as “ contact-dependent ” signaling and<br />

involves the expression and activation <strong>of</strong> GPIIb-IIIa receptors<br />

( Shattil and Newman, 2004 ). GPIIb-IIIa is the most<br />

abundant integrin on the platelet surface and is not only<br />

necessary for platelet-platelet aggregation but also for<br />

platelet secretion, the development <strong>of</strong> procoagulant activity,<br />

and clot retraction. This integrin is typical <strong>of</strong> type 1<br />

membrane receptors in that it contains a relatively large

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!